De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Arcoma Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Arcoma heeft een totaal eigen vermogen van SEK56.5M en een totale schuld van SEK2.4M, wat de schuld-eigenvermogensverhouding op 4.2% brengt. De totale activa en totale passiva bedragen respectievelijk SEK83.7M en SEK27.2M. De EBIT Arcoma is SEK14.0M waardoor de rentedekking 18.6 is. Het heeft contanten en kortetermijnbeleggingen van SEK8.5M.

Belangrijke informatie

4.2%

Verhouding schuld/eigen vermogen

SEK 2.40m

Schuld

Rente dekkingsratio18.6x
ContantSEK 8.54m
AandelenSEK 56.49m
Totaal verplichtingenSEK 27.24m
Totaal activaSEK 83.74m

Recente financiële gezondheidsupdates

Recent updates

Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

Aug 22
Solid Earnings Reflect Arcoma's (STO:ARCOMA) Strength As A Business

At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Aug 07
At kr15.20, Is Arcoma AB (STO:ARCOMA) Worth Looking At Closely?

Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Apr 26
Is Now The Time To Look At Buying Arcoma AB (STO:ARCOMA)?

Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Feb 06
Arcoma AB's (STO:ARCOMA) P/E Is Still On The Mark Following 25% Share Price Bounce

Is Arcoma (STO:ARCOMA) A Risky Investment?

Jan 15
Is Arcoma (STO:ARCOMA) A Risky Investment?

We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Sep 11
We Think Arcoma (STO:ARCOMA) Is Taking Some Risk With Its Debt

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Jun 08
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Apr 27
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Dec 22
Does Arcoma (STO:ARCOMA) Have A Healthy Balance Sheet?

Is Arcoma (STO:ARCOMA) Using Too Much Debt?

May 03
Is Arcoma (STO:ARCOMA) Using Too Much Debt?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Oct 28
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Extensively

Is Arcoma (STO:ARCOMA) A Risky Investment?

Mar 17
Is Arcoma (STO:ARCOMA) A Risky Investment?

Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Feb 04
Is Arcoma AB (STO:ARCOMA) Potentially Undervalued?

Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Jan 14
Have Insiders Sold Arcoma AB (STO:ARCOMA) Shares Recently?

Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Jan 12
Arcoma AB's (STO:ARCOMA) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Dec 17
These 4 Measures Indicate That Arcoma (STO:ARCOMA) Is Using Debt Reasonably Well

Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

Nov 21
Estimating The Fair Value Of Arcoma AB (STO:ARCOMA)

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SEK57.4M ) ARCOMA } overtreffen de korte termijn passiva ( SEK25.7M ).

Langlopende schulden: De kortetermijnactiva ARCOMA ( SEK57.4M ) overtreffen de langetermijnschulden ( SEK1.6M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: ARCOMA heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van ARCOMA is de afgelopen 5 jaar gedaald van 43.9% naar 4.2%.

Schuldendekking: De schuld van ARCOMA wordt goed gedekt door de operationele kasstroom ( 916.8% ).

Rentedekking: De rentebetalingen op de schuld van ARCOMA worden goed gedekt door EBIT ( 18.6 x dekking).


Balans


Ontdek gezonde bedrijven